MiR-155 Is a Liposarcoma Oncogene That Targets Casein Kinase-1 and Enhances -Catenin Signaling
Cancer Research - United States
doi 10.1158/0008-5472.can-11-3027
Full Text
Open PDFAbstract
Available in full text
Date
February 20, 2012
Authors
Publisher
American Association for Cancer Research (AACR)